|本期目录/Table of Contents|

[1]蔡 隽 综述,冯玉梅 审校.叉头框转录因子调控乳腺癌生物学特性的研究进展[J].天津医科大学学报,2015,21(05):455-458.
点击复制

叉头框转录因子调控乳腺癌生物学特性的研究进展(PDF)
分享到：

《天津医科大学学报》[ISSN:1006-8147/CN:12-1259/R]

卷:
21卷
期数:
2015年05期
页码:
455-458
栏目:
综述
出版日期:
2015-09-20

文章信息/Info

Title:
-
文章编号:
1006-8147(2015)05-0455-04
作者:
蔡 隽 综述; 冯玉梅 审校
（天津医科大学附属肿瘤医院，国家肿瘤临床医学研究中心，天津市肿瘤防治重点实验室，乳腺癌防治教育部重点实验室，天津300060 ）
Author(s):
-
关键词:
叉头框转录因子; 乳腺癌; 生物学特性
Keywords:
-
分类号:
R737.9
DOI:
-
文献标志码:
A
摘要:
-
Abstract:
-

参考文献/References:

[1]Goldhirsch A, Wood W C, Coates A S, et al. Strategies for subtypes--dealing with the diversity of breast cancer: highlights of the St. Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2011[J].Ann Oncol,2011,22(8):1736

[2]Eroles P, Bosch A, Alejandro Perez-Fidalgo J, et al. Molecular biology in breast cancer: Intrinsic subtypes and signaling pathways[J].Cancer Treat Rev,2012,38(6):698

[3]Karihtala P, Auvinen P, Kauppila S, et al. Vimentin, zeb1 and sip1 are up-regulated in triple-negative and basal-like breast cancers: association with an aggressive tumour phenotype[J].Breast Cancer Res Treat,2013,138(1):81

[4]Hollier B G, Tinnirello A A, Werden S J, et al. FOXC2 expression links epithelial-mesenchymal transition and stem cell properties in breast cancer[J].Cancer Res,2013,73(6):1981

[5]Zhang H J, Meng F Y, Liu G, et al. Forkhead transcription factor Foxq1 promotes epithelial-mesenchymal transition and breast cancer metastasis[J].Cancer Res,2011,71(4):1292

[6]Benayoun B A, Caburet S, Veitia R A. Forkhead transcription factors: key players in health and disease[J].Trends Genet,2011,27(6):224

[7]Katoh M, Igarashi M, Fukuda H, et al. Cancer genetics and genomics of human Fox family genes[J].Cancer Lett,2013,328(2):198

[8]Bernardo G M, Lozada K L, Miedler J D, et al. FOXA1 is an essential determinant of ER alpha expression and mammary ductal morphogenesis[J].Development,2010,137(12):2045

[9]Laganière J, Deblois G, Lefebvre C, et al. From the cover: location analysis of estrogen receptor alpha target promoters reveals that FOXA1 defines a domain of the estrogen response[J].Proc Natl Acad Sci U S A,2005,102(33):11651

[10]Robinson J L, Macarthur S, Ross-Innes C S, et al. Androgen receptor driven transcription in molecular apocrine breast cancer is mediated by FoxA1[J].EMBO J,2011,30(15):3019

[11]Serandour A A, Avner S, Percevault F A, et al. Epigenetic Switch involved in activation of pioneer factor FOXA1-dependent enhancers[J].Genome Res,2011,21(4):555

[12]Ghosh S, Gu F, Wang C M, et al. Genome-wide DNA methylation profiling reveals parity-associated hypermethylation of FOXA1[J].Breast Cancer Res Treat,2014,147(3):653

[13]Theodorou V, Stark R, Menon S, et al. GATA3 acts upstream of FOXA1 in mediating ESR1 binding by shaping enhancer accessibility[J].Genome Res,2013,23(1):12

[14]Wang C Y, Mayer J A, Mazumdar A, et al. The rearranged during transfection/papillary thyroid carcinoma tyrosine kinase is an estrogen-dependent gene required for the growth of estrogen receptor positive breast cancer cells[J].Breast Cancer Res Treat,2012, 133(2):487

[15]Malik S, Jiang S M, Garee J P, et al. Histone deacetylase 7 and FoxA1 in Estrogen-Mediated repression of RPRM[J].Mol Cell Biol,2010,30(2):399

[16]Williamson E A, Wolf I, O’kelly J, et al. BRCA1 and FOXA1 proteins coregulate the expression of the cell cycle-dependent kinase inhibitor p27(Kip1)[J].Oncogene,2006,25(9):1391

[17]Bernardo G M, Bebek G, Ginther C L, et al. FOXA1 represses the molecular phenotype of basal breast cancer cells[J].Oncogene, 2013,32(5):554

[18]Naderi A, Meyer M, Dowhan D H. Cross-regulation between FOXA1 and ErbB2 signaling in estrogen receptor-negative breast cancer[J]. Neoplasia, 2012,14(4):283

[19]Badve S, Turbin D, Thorat M A, et al. FOXA1 expression in breast cancer - correlation with luminal subtype A and survival[J].Clin Cancer Res,2007,13(15, 1):4415

[20]Kawase M, Toyama T, Takahashi S, et al. FOXA1 expression after neoadjuvant chemotherapy is a prognostic marker in estrogen receptor-positive breast cancer[J].Breast Cancer,2013 . [Epub ahead of print]

[21]Cappelletti V, Fina E, Miodini P, et al. Gene expression profiling of circulating tumor cells in breast cancer[J].Clin Chem, 2011,47(4):12

[22]Ray P S, Wang J H, Qu Y, et al. FOXC1 is a potential prognostic biomarker with functional significance in basal-like breast cancer[J].Cancer Res,2010,70(10):3870

[23]Jin Y L, Han B C, Chen J Y, et al. FOXC1 is a critical mediator of EGFR function in human basal-like breast cancer[J].Ann Surg Oncol,2014,21(4):758

[24]Mortazavi F, An J B, Dubinett S, et al. p120-Catenin is transcriptionally downregulated by FOXC2 in Non-Small cell lung cancer cells[J].Mol Cancer Res,2010,8(5):762

[25]Feuerborn A, Srivastava P K, Kueffer S, et al. The forkhead factor FoxQ1 influences epithelial differentiation[J].J Cell Physiol,2011,226(3):710

[26]Wang J, Ray P S, Sim M S, et al. FOXC1 regulates the functions of human basal-like breast cancer cells by activating NF-kappa B signaling[J].Oncogene,2012,31(45):4798

[27]Kaneda H, Arao T, Tanaka K, et al. FOXQ1 is overexpressed in colorectal Cancer and enhances tumorigenicity and tumor growth[J].Cancer Res,2010,70(5):2053

[28]Tammela T, Zarkada G, Nurmi H, et al. VEGFR-3 controls tip to stalk conversion at vessel fusion sites by reinforcing Notch signalling[J].Nat Cell Biol,2011,13(10):1202

[29]Kume T. The role of FoxC2 transcription factor in tumor angiogenesis[J].J Oncol,2012，2012:204593

[30]Mallini P, Lennard T, Kirby J, et al. Epithelial-to-mesenchymal transition: What is the impact on breast cancer stem cells and drug resistance[J].Cancer Treat Rev,2014,40(3):341

[31]Qiao Y Y, Jiang X, Lee S T, et al. FOXQ1 regulates epithelial-mesenchymal transition in human cancers[J].Cancer Res,2011,71(8):3076

[32]Zhang Y J, Zhang N, Dai B B, et al. FoxM1B transcriptionally regulates vascular endothelial growth factor expression and promotes the angiogenesis and growth of glioma cells[J].Cancer Res,2008, 68(21): 8733

[33]Li D, Mei H, Qi M, et al. FOXD3 is a novel tumor suppressor that affects growth, invasion, metastasis and angiogenesis of neuroblastoma[J]. Oncotarget,2013,4(11):2021

[34]Kong P Z, Yang F, Li L, et al. Decreased FOXF2 mRNA expression indicates early-onset metastasis and poor prognosis for breast Cancer patients with histological grade II tumor[J].PLoS One, 2013, 8 (4): 61591

相似文献/References:

[1]朱悦,张诗武,张丹芳,等.TA2小鼠自发乳腺癌血清蛋白质组学研究[J].天津医科大学学报,2013,19(05):373.
[2]刘 营,孙保存,刘铁菊,等.AURKA蛋白激酶在三阴乳腺癌干细胞形成血管拟态中的实验研究[J].天津医科大学学报,2013,19(06):437.
　LIU Ying,SUN Bao-cun,LIU Tie-ju,et al.Experimental study of AURKA protein kinase in the formation of vascular mimicry in triple-negative breast cancer stem cells[J].Journal of Tianjin Medical University,2013,19(05):437.
[3]伦淑敏.HOXA5基因真核表达质粒的构建及在乳腺癌细胞中的功能研究[J].天津医科大学学报,2014,20(05):337.
　LUN Shu-min. Construction of HOXA5 eukaryotic expression plasmid of and its biological significance in breast cancer cells[J].Journal of Tianjin Medical University,2014,20(05):337.
[4]伦淑敏.肌细胞增强因子2A基因真核表达质粒的构建及对乳腺癌细胞MCF-7增殖能力的影响[J].天津医科大学学报,2014,20(06):429.
　LUN Shu-min.Construction of myocyte enhancer factor 2A eukaryotic expression plasmid and effects on cell proliferation in breast cancer cell line MCF7[J].Journal of Tianjin Medical University,2014,20(05):429.
[5]孙秀梅,张 飞,田 然,等.Nanog表达上调促进乳腺癌细胞MCF-7的增殖和侵袭[J].天津医科大学学报,2014,20(06):421.
　SUN Xiu-mei,ZHANG Fei,TIAN Ran,et al.Up-regulation of Nanog promotes cell proliferation and invasion in breast cancer cells MCF-7[J].Journal of Tianjin Medical University,2014,20(05):421.
[6]张 洁,张 飞,冀 为,等. SHP2不同突变体对乳腺癌细胞的迁移和侵袭能力的影响[J].天津医科大学学报,2015,21(02):93.
　ZHANG Jie,ZHANG Fei,JI Wei,et al. Effect of different SHP2 mutants on breast cancer cell migration and invasion[J].Journal of Tianjin Medical University,2015,21(05):93.
[7]蔡 隽. FOXQ1稳定表达乳腺癌细胞系的建立及鉴定[J].天津医科大学学报,2015,21(04):292.
　CAI Jun.Establishment and identification of cell lines with stable expression of FOXQ1 in MDA-MB-231-luc[J].Journal of Tianjin Medical University,2015,21(05):292.
[8]任宗娜.沉默Notch4基因对乳腺癌细胞系MDA-MB-231增殖和迁移侵袭能力的影响[J].天津医科大学学报,2015,21(06):469.
　REN Zong-na.Inhibition effect of?silencing?? Notch4 gene on the proliferation and migration and invasion activity of? breast cancer cell line?MDA-MB-231[J].Journal of Tianjin Medical University,2015,21(05):469.
[9]周岩,宋伟杰,张飞,等.人附睾蛋白4在乳腺癌发生发展中的机制研究[J].天津医科大学学报,2015,21(06):466.
　ZHOU Yan,SONG Wei-jie,ZHANG Fei,et al.Mechanism of human epididymis protein 4 in development and progression of breast cancer[J].Journal of Tianjin Medical University,2015,21(05):466.
[10]刘晓丽,黄 勇,杨丽敏,等.二氢嘧啶脱氢酶基因的T85C和A1627G联合突变对乳腺癌患者预后的影响[J].天津医科大学学报,2016,22(05):412.
　LIU Xiao-li,HUANG Yong,YANG Li-min,et al.Effect of combined mutations of T85C and A1627G in dihydropyrimidine dehydrogenase gene on prognosis of patients with breast cancer[J].Journal of Tianjin Medical University,2016,22(05):412.

备注/Memo

备注/Memo:
作者简介 蔡隽（1989-），女，硕士在读，研究方向：生物化学与分子生物学；

E-mail:caijun9865@126.com。

更新日期/Last Update: 2015-09-22